Crohn's Disease and Colitis Trial, Recruiting (NCT05321745)

Crohn's Disease and Colitis Trial, Recruiting NCT05321745 Sponsor: Biao Zou Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT05321745 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Children between 2 and 16 years old who do not have a genetic disease
Children who have mild-to-moderate Crohn's disease, based on specific activity scores measured by their doctor (confirm with trial site)
Children whose Crohn's disease has not responded to standard treatments, including steroids, medications that suppress the immune system, or biologic drugs

Who may not be able to join:

Children who have received a specific type of nutritional feeding programme (called PEN at 80%) for less than 8 weeks
Children who cannot commit to being followed up for at least 3 months
Children who are unable to receive treatment through any of the available methods used in this trial, such as a tube through the nose into the gut, camera procedures of the gut, an enema, or a swallowable capsule
Children or their parents/guardians who are not willing to sign a consent form agreeing to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 15 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sainan Shu, MD, PhD, Tongji Hospital

Phone: 027-83663594

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05321745

Sponsor: Biao Zou

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: 027-83663594

More information: https://clinicaltrials.gov/study/NCT05321745

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Children between 2 and 16 years old who do not have a genetic disease
Children who have mild-to-moderate Crohn's disease, based on specific activity scores measured by their doctor (confirm with trial site)
Children whose Crohn's disease has not responded to standard treatments, including steroids, medications that suppress the immune system, or biologic drugs

Who may not be able to join:

Children who have received a specific type of nutritional feeding programme (called PEN at 80%) for less than 8 weeks
Children who cannot commit to being followed up for at least 3 months
Children who are unable to receive treatment through any of the available methods used in this trial, such as a tube through the nose into the gut, camera procedures of the gut, an enema, or a swallowable capsule
Children or their parents/guardians who are not willing to sign a consent form agreeing to take part in the study

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 15 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Biao Zou

Registry

ClinicalTrials.gov

Start date

22 March 2022

Est. completion

31 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Clinical remission; Endoscopic remission; Mucosal healing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov